Calcitonin Gene-Related Peptide Antagonists as Treatments of Migraine and Other Primary Headaches

ISSN： 0012-6667

Source： Drugs, Vol.65, Iss.18, 2005-01, pp. : 2557-2567

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Calcitonin gene-related peptide receptor antagonists for migraine

By Fischer Michael JM

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 7, 2010-07 ,pp. : 815-823

Informa Healthcare

Access to resources Recommend Favorite

Calcitonin Gene-Related Peptide (CGRP) Receptor Antagonists in the Treatment of Migraine

By Durham Paul L. Vause Carrie V.

CNS Drugs, Vol. 24, Iss. 7, 2010-07 ,pp. : 539-548

Adis International

Access to resources Recommend Favorite

Modelling the Anti-Migraine Effects of BIBN 4096 BS: A New Calcitonin Gene-Related Peptide Receptor Antagonist

By Trocóniz Iñaki F.

Clinical Pharmacokinetics, Vol. 45, Iss. 7, 2006-01 ,pp. : 715-728

Adis International

Access to resources Recommend Favorite

Discovery techniques for calcitonin gene-related peptide receptor antagonists for potential antimigraine therapies

By Labruijere Sieneke Ibrahimi Khatera Chan Kayi Y MaassenVanDenBrink Antoinette

Expert Opinion on Drug Discovery, Vol. 8, Iss. 11, 2013-11 ,pp. : 1309-1323

Informa Healthcare

Access to resources Recommend Favorite

Calcitonin gene-related peptide as inflammatory mediator

By Springer J. Geppetti P. Fischer A. Groneberg D.A.

Pulmonary Pharmacology & Therapeutics, Vol. 16, Iss. 3, 2003-06 ,pp. : 121-130

Elsevier

Access to resources Recommend Favorite